BE1014522A5 - Composition pharmaceutique et son utilisation. - Google Patents

Composition pharmaceutique et son utilisation. Download PDF

Info

Publication number
BE1014522A5
BE1014522A5 BE2001/0452A BE200100452A BE1014522A5 BE 1014522 A5 BE1014522 A5 BE 1014522A5 BE 2001/0452 A BE2001/0452 A BE 2001/0452A BE 200100452 A BE200100452 A BE 200100452A BE 1014522 A5 BE1014522 A5 BE 1014522A5
Authority
BE
Belgium
Prior art keywords
sep
brivudine
acyclovir
treatment
magnesium stearate
Prior art date
Application number
BE2001/0452A
Other languages
English (en)
French (fr)
Inventor
Alessandro Casini
Bettina Stubinski
Attilio Crea
Original Assignee
Berlin Chemie Ag
Menarini Ricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlin Chemie Ag, Menarini Ricerche Spa filed Critical Berlin Chemie Ag
Application granted granted Critical
Publication of BE1014522A5 publication Critical patent/BE1014522A5/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BE2001/0452A 2001-01-03 2001-07-04 Composition pharmaceutique et son utilisation. BE1014522A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI000009A ITMI20010009A1 (it) 2001-01-03 2001-01-03 Composizioni farmaceutica contenente brivudina per la singola somministrazione giornaliera

Publications (1)

Publication Number Publication Date
BE1014522A5 true BE1014522A5 (fr) 2003-12-02

Family

ID=11446384

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2001/0452A BE1014522A5 (fr) 2001-01-03 2001-07-04 Composition pharmaceutique et son utilisation.

Country Status (20)

Country Link
AT (1) AT6141U1 (da)
BE (1) BE1014522A5 (da)
CH (1) CH695662A5 (da)
CZ (1) CZ20012464A3 (da)
DK (1) DK177084B1 (da)
ES (1) ES2192456B1 (da)
FI (1) FI20011446A (da)
FR (1) FR2818907B1 (da)
GB (1) GB2370771A (da)
GR (1) GR1004012B (da)
HR (1) HRPK20010345B3 (da)
HU (1) HUP0102816A3 (da)
IE (1) IE20010413A1 (da)
IT (1) ITMI20010009A1 (da)
NL (1) NL1018431C2 (da)
PL (1) PL348480A1 (da)
PT (1) PT102642B (da)
SE (1) SE0102309L (da)
SK (1) SK287043B6 (da)
UA (1) UA76402C2 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2239527B1 (es) * 2004-03-01 2006-11-16 M. Cruz Fernandez Gonzalez Composicion farmacologica de uso topico para el tratamiento del herpes zoster.
CN113712928A (zh) * 2021-09-29 2021-11-30 重庆市力扬医药开发有限公司 经口腔粘膜吸收的溴夫定药物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0104857A1 (en) * 1982-09-28 1984-04-04 Beecham Group Plc Deoxyuridine compounds, methods for preparing them and their use in medicine
US5446031A (en) * 1991-04-24 1995-08-29 Yamasa Shuyu Kabushiki Kaisha 1-β-D-arabinofuranosyl-(E)-5-(2-halogenovinyl)uracil derivatives
WO1997025989A1 (en) * 1996-01-19 1997-07-24 Glaxo Group Limited Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170232B (it) * 1983-10-31 1987-06-03 Anna Gioia Stendardi Composizioni terapeutiche ad attivita' antivirale

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0104857A1 (en) * 1982-09-28 1984-04-04 Beecham Group Plc Deoxyuridine compounds, methods for preparing them and their use in medicine
US5446031A (en) * 1991-04-24 1995-08-29 Yamasa Shuyu Kabushiki Kaisha 1-β-D-arabinofuranosyl-(E)-5-(2-halogenovinyl)uracil derivatives
WO1997025989A1 (en) * 1996-01-19 1997-07-24 Glaxo Group Limited Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Behandlung mit Brivudin: Einmal täglich: das reicht für effektive Zoster-Therapie", CRTZE ZEITUNG, 18 December 2000 (2000-12-18), XP002199673, Retrieved from the Internet <URL:http://www.arztonline.de/docs/2000/12/18/228a0403.asp#top> [retrieved on 20020522] *
OLGEMOLLER J ET AL: "Determination of (E)-5-(2-bromovinyl)-2'-deoxyuridine in plasma and urine by capillary electrophoresis", JOURNAL OF CHROMATOGRAPHY B: BIOMEDICAL APPLICATIONS, ELSEVIER SCIENCE PUBLISHERS, NL, vol. 726, no. 1-2, 16 April 1999 (1999-04-16), pages 261 - 268, XP004165297, ISSN: 0378-4347 *

Also Published As

Publication number Publication date
SE0102309D0 (sv) 2001-06-28
SK9572001A3 (en) 2003-03-04
HRPK20010345B3 (en) 2005-02-28
GR1004012B (el) 2002-11-01
ITMI20010009A0 (it) 2001-01-03
HU0102816D0 (en) 2001-09-28
GR20010100322A (el) 2002-10-08
GB0110682D0 (en) 2001-06-20
AT6141U1 (de) 2003-05-26
PT102642B (pt) 2003-06-30
SE0102309L (sv) 2002-07-04
GB2370771A (en) 2002-07-10
FI20011446A0 (fi) 2001-07-03
PL348480A1 (en) 2002-07-15
PT102642A (pt) 2002-07-31
CH695662A5 (de) 2006-07-31
IE20010413A1 (en) 2003-04-16
HUP0102816A2 (en) 2002-10-28
HRP20010345A2 (en) 2003-08-31
FI20011446A (fi) 2002-07-04
HUP0102816A3 (en) 2005-01-28
FR2818907A1 (fr) 2002-07-05
DK200101019A (da) 2002-07-04
SK287043B6 (sk) 2009-10-07
NL1018431C2 (nl) 2002-07-05
DK177084B1 (da) 2011-07-11
ES2192456A1 (es) 2003-10-01
ITMI20010009A1 (it) 2002-07-03
UA76402C2 (en) 2006-08-15
CZ20012464A3 (cs) 2002-08-14
FR2818907B1 (fr) 2006-05-26
ES2192456B1 (es) 2005-02-01

Similar Documents

Publication Publication Date Title
JP5507791B2 (ja) ピリミジンを含有するｎｎｒｔｉとｒｔインヒビターとの組み合わせ物
EP0278821B1 (fr) Utilisation d&#39;antagonistes de la morphine dans la préparation de médicaments à effet immunomodulateur et anti-viral, destinés notamment à traiter les états immuno-déficitaires acquis
JPH05194227A (ja) 薬 剤
HUP0400553A2 (hu) Gyógyászati készítmények
KR20230145439A (ko) Irak4 분해제 및 이의 용도
TW200838503A (en) Pharmaceutical composition
EP3454848B1 (en) 5ht6 receptor antagonists for use in the treatment of alzheimer&#39;s disease with apathy as comorbidity
BE1014522A5 (fr) Composition pharmaceutique et son utilisation.
EP3405197B1 (en) Use of delgocitinib for the treatment of chronic hand eczema
CN112294820B (zh) 一种减少高血压患者血管内皮损伤的组合物
EP2509586B1 (en) Mucoadhesive buccal tablets for the treatment of orofacial herpes
JP2006528949A5 (da)
DE69903546T2 (de) Levosimendan für die behandlung von pulmonaler hypertonie
JP2002523363A5 (da)
US20190269691A1 (en) Pharmaceutical Composition for the Treatment of Acute Tooth or Jaw Pain
NL8600137A (nl) Farmaceutische preparaten die desgewenst met een diureticum gecombineerde 3-aminopropoxyindolen bevatten, alsmede werkwijzen voor het toepassen van deze preparaten.
KR20220108123A (ko) 치매 환자의 행동 및 심리적 증상 치료
US20040192706A1 (en) Method and compositions for treating anxiety
EP1945226B1 (en) Drug combination with analgesic, anti-inflammatory and decongestive activity
Blonsky et al. Phase II multiclinic study of elantrine in parkinsonism
JP2001089375A (ja) 感冒用組成物
EA005497B1 (ru) Применение фармацевтической композиции, содержащей бривудин, для лечения герпесвирусных инфекций
Bennett, JM,* Weich, DJV** & Schoeman Double-blind study comparing indoramin and propranolol in the treatment of black patients with hypertension
RO121585B1 (ro) Utilizarea brivudinei în tratamentul infectiilor de tip herpes zoster sau nevralgiei post-herpetice
SI20854A (sl) Farmacevtska zmes z učinkovino Brivudine z enkratnim dnevnim doziranjem

Legal Events

Date Code Title Description
MK Patent expired because of reaching the maximum lifetime of a patent

Effective date: 20210704